230 filings
10-Q
2024 Q1
SYRS
Syros Pharmaceuticals Inc.
Quarterly report
14 May 24
6:42am
ARS
2023 FY
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Annual report to shareholders
7:10am
DEFA14A
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Additional proxy soliciting materials
7:05am
DEF 14A
SYRS
Syros Pharmaceuticals Inc.
Definitive proxy
23 Apr 24
7:01am
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
S-8
wrnzycx chau
27 Mar 24
Registration of securities for employees
7:04am
8-K
m85 y2w6sg7
8 Jan 24
Regulation FD Disclosure
7:06am
8-K
q53p6407irfsfanyz
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B5
26ywuoxotc1rqum6bv
19 Dec 23
Prospectus supplement for primary offering
4:53pm
8-K
8r746iap
6 Dec 23
Regulation FD Disclosure
7:05am
8-K
z8f 025h6
2 Oct 23
Cost Associated with Exit or Disposal Activities
8:49am
8-K
35hz dya2wm7097il0
11 Aug 23
Termination of a Material Definitive Agreement
4:30pm
8-K
xcu7g2
21 Jul 23
Termination of a Material Definitive Agreement
4:36pm
8-K
5eh2x070srfzdo
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
l66wuvc0g2o3 t3tkgj1
25 May 23
Regulation FD Disclosure
5:10pm
424B5
ds1lkb
1 May 23
Prospectus supplement for primary offering
4:06pm